JNJ
NYSE Johnson & Johnson$271.95 ↑ +0.00 (+0.00%) Trading Up from the previous close of $271.95, $1.83 below the day’s high of $273.78
- YTD change
- +31.41%
- vs 20-day SMA
- +0.86%
- vs 200-day SMA
- +13.16%
Price ranges
Price & Performance
+29.46 (+12.15%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 3.2% away from all-time highs of $281.07
- JNJ is up 31% since the beginning of the year
- JNJ is up 51% over the past 12 months
- JNJ is up 2% over the past 1 month
- 1% of all JNJ investors are betting against JNJ
- Number of investors short JNJ has gone down 17% versus last month
JNJ reads very good: price sits above both the 20- and 200-day averages, short interest is falling month over month, the 12-month move is +49.7%.
- Previous minute
- +$0.49
- Last hour
- +$0.54
- Last 5 days
- +0.73%
- vs 8-day SMA
- +0.85%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.
